Mobidiag to Develop Additional Dxs for Bacteria, Sepsis; Continues STM Alliance | GenomeWeb
Fresh from launching its array-based Prove-it Herpes diagnostic last week, Finnish molecular diagnostics firm Mobidiag said it plans to develop similar tests for sepsis and multiple bacterial infections.
 
The company said Prove-it Herpes, which tests for eight different human herpes viruses in a single sample, may eventually replace the slower, PCR-based assays currently used in European clinical labs and hospitals. These assays test for a single human herpes virus at a time.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.